Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise and neurofeedback versus methylphenidate for ADHD
2010-020508-31Phase 4Active
- Sponsor
- ZonMw
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by ZonMw. Primary endpoints: Behavioral improvement, Neurocognitive improvement and 1 more. Started May 2010; status: active.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2010-020508-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020508-31.